Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Nowa Sol – page 7

83 clinical trials in Nowa Sol, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Nowa Sol at a glance
83
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

83 trials in Nowa Sol

Open in trial search

Alopecia areata

Not recruiting

Study on Rezpegaldesleukin for Treating Severe Alopecia Areata in Adults

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rezpegaldesleukin
  • Sponsor:Nektar Therapeutics

Conjunctivitis allergic+1

Not recruiting

Study on Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Betula Pendula Pollen Allergoid, Mannan-Conjugated, Polymerised
  • Sponsor:CCDRD Cooperative Clinical Drug Research and Development AG

Study on the Effects of Bexotegrast for Patients with Idiopathic Pulmonary Fibrosis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bexotegrast
  • Sponsor:Pliant Therapeutics Inc.

Rheumatoid arthritis

Not recruiting

Study on Rosnilimab for Patients with Moderate to Severe Rheumatoid Arthritis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rosnilimab
  • Sponsor:Anaptysbio Inc.

Psoriatic arthropathy

Not recruiting

Study on Guselkumab for Treating Active Psoriatic Arthritis in Patients with Inadequate Response to One Prior Anti-TNF Agent

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International

Dermatitis atopic

Not recruiting

Study on the Safety and Effectiveness of ADX-914 for Patients with Moderate to Severe Atopic Dermatitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bempikibart
  • Sponsor:Q32 Bio Inc.

Psoriatic arthropathy

Not recruiting

Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Psoriatic Arthritis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bimekizumab
  • Sponsor:UCB Biopharma

Psoriasis

Not recruiting

Study on Bimekizumab and Ustekinumab for Children and Teens with Moderate to Severe Plaque Psoriasis

Investigational
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Bimekizumab
  • Sponsor:UCB Biopharma

Partial seizures

Not recruiting

Study of EQU-001 and Placebo for Patients with Uncontrolled Focal Seizures in Epilepsy

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ivermectin
  • Sponsor:Equilibre Biopharmaceuticals B.V.

Partial seizures

Not recruiting

Study on the Effects of Azetukalner in Reducing Focal-Onset Seizures for Patients with Epilepsy

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Azetukalner
  • Sponsor:Xenon Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Telitacicept
  • Sponsor:Vor Biopharma Inc.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Nowa Sol

What the registry says about research in the country

01 Rheumatology Studies

Innovative research focusing on psoriatic arthritis and rheumatoid arthritis treatments, evaluating new biological therapies and biosimilars for improved patient outcomes.

  • Zasocitinib for psoriatic arthritis
  • Tocilizumab biosimilar studies
  • Rosnilimab efficacy trials

Multiple studies are investigating novel therapeutic approaches for patients who haven't responded to conventional treatments.

02 Dermatological Conditions

Comprehensive research into atopic dermatitis and plaque psoriasis, including studies for both adult and pediatric populations.

  • Bimekizumab for plaque psoriasis
  • Lunsekimig for atopic dermatitis
  • ADX-914 clinical evaluation

These trials aim to advance treatment options for moderate to severe skin conditions.

03 Autoimmune Disorders

Groundbreaking research in Sjögren's Syndrome and systemic lupus erythematosus, testing novel therapeutic approaches.

  • Dazodalibep safety studies
  • Anifrolumab subcutaneous administration
  • Systemic sclerosis treatments

Focus on developing targeted therapies for complex autoimmune conditions.

04 Neurological Research

Studies addressing epilepsy and Alzheimer's-related conditions, including innovative treatment approaches for seizure management.

  • XEN1101 for seizure control
  • Alzheimer's agitation treatment
  • Staccato alprazolam evaluation

Research aims to improve quality of life for patients with neurological disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.